St Jude Medical Inc. (STJ)

NYSE: Health Care

Add Comment

$42.78

-0.15 | -0.35%

Today's Range: 42.18 - 42.80

STJ Avg. Daily Volume: 3,989,600

02/10/12 - 4:00 PM ET

TRADE NOW

Company Cash Flow

Cash Flow From Operating Activities
	Dec 2011	Dec 2010	Dec 2009	Dec 2008
Net Income (Loss)	0.00	907.44M	777.23M	384.33M
Operating Gains/Losses	n.a.	-4.93M	5.84M	319.35M
Extraordinary Gains / Losses	n.a.	0.00	0.00	0.00
(Increase) Decrease In Receivables	n.a.	-123.30M	-39.09M	-92.30M
(Increase) Decrease in Inventories	n.a.	42.32M	-104.46M	-87.53M
(Increase) Decrease In Other Current Assets	n.a.	-30.92M	10.30M	-20.03M
(Decrease) Increase In Payables	n.a.	163.56M	-65.10M	55.42M
(Decrease) Increase In Other Current Liabilities	0.00	11.90M	30.68M	84.20M
(Increase) Decrease In Other Working Capital	n.a.	0.00	0.00	0.00
Other Non-Cash Items	n.a.	96.66M	53.70M	131.43M
Net Cash From Continuing Operations	n.a.	1.27B	868.88M	945.59M
Net Cash From Discontinued Operations	n.a.	0.00	0.00	0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	0.00	1.27B	868.88M	945.59M
Sale of Property, Plant & Equipment	n.a.	0.00	0.00	0.00
Cash Used for Investing Activities
Sale of Short-Term Investments	n.a.	0.00	0.00	0.00
Purchases of Property, Plant & Equipment	0.00	-304.90M	-326.41M	-343.91M
Acquisitions	n.a.	-679.02M	-129.51M	-490.03M
Purchases of Short-Term Investments	n.a.	0.00	0.00	0.00
Other Cash from Investing Activities	0.00	-104.89M	-34.67M	0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	0.00	-1.08B	-490.58M	-871.07M
Issuance of Debt	0.00	1.19B	11.15B	967.62M
Cash Used for Financing Activities
Issuance of Capital Stock	n.a.	151.77M	126.26M	166.01M
Repayment of Long-Term Debt	0.00	-852.69M	-10.44B	0.00
Repurchase of Capital Stock	0.00	-590.79M	-1.00B	-300.00M
Payment of Cash Dividends	0.00	0.00	0.00	0.00
Other Financing Charges, Net	n.a.	16.64M	26.37M	-1.16B
Net Cash From Financing Activities	0.00	-86.55M	-130.70M	-322.49M
Effect of Exchange Rate Changes	0.00	-26.00K	8.89M	-4.68M
Net Change in Cash & Cash Equivalents	0.00	107.41M	256.48M	-252.65M

Latest STJ Headlines

More Financial News for STJ

Press Releases for STJ

St. Jude Medical Reports Fourth Quarter And Full-Year 2011 Results - Business Wire
Independent Data Safety Monitoring Board Recommends St. Jude Medical's FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis - Business Wire
Data From St. Jude Medical's ASSERT Implantable Device Monitoring Study Published In New England Journal Of Medicine - Business Wire
The Libra(TM) Deep Brain Stimulation (DBS) System Is Approved In Europe And Australia For Treating The Symptoms Of Parkinson's Disease And Is Being Evaluated In U.S. Clinical Trials For Parkinson's Disease And Essential Tremor. (Photo: St. Jude Medical Inc.) - Business Wire
St. Jude Medical Announces Preliminary Fourth Quarter Revenue Results - Business Wire
Proposed St. Jude Medical Expansion - Plymouth Campus (Graphic: St. Jude Medical, Inc.) - Business Wire
St. Jude Medical To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire
St. Jude Medical Announces Achievement Of Stopping Rule And Closing Of Patient Enrollment In RESPECT Clinical Trial - Business Wire
St. Jude Medical Launches Riata Communication Website - Business Wire
FDA Classifies Voluntary Physician Advisory Letter On Riata And Riata ST Silicone Defibrillation Leads As Class I Recall (URGENT MEDICAL DEVICE ADVISORY) - Business Wire

See all press releases.

STJ Ideas

Refresh Stock Quote for St Jude Medical Inc. - STJ

TheStreet Premium Services For Personal Service: 877-471-2967

Compare All Services

Jim Cramer's Action Alerts PLUS:

Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More

ETF Profits:

Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More

OptionsProfits:

Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More

Real Money:

Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More

Stocks Under $10:

Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More

Dow Jones	S&P 500	NASDAQ	10-Year Note
12,801.23	1,342.64	2,903.88	19.69	Oil * 117.67
DOWN 89.23	DOWN 9.31	DOWN 23.35	DOWN 0.78	10 Yr 1.97% SPDR Gold 167.14
-0.69%	-0.69%	-0.80%	-3.81%	Data delayed 20 minutes